NCT00638391View on ClinicalTrials.gov

Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer

CompletedOBSERVATIONAL

Enrollment

1,600

Participants

Timeline

Start Date

May 31, 2005

Study Completion Date

March 31, 2007

Conditions

Breast Cancer

Interventions

DRUG

Anastrozole

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY